2025. Baricitinib Achieved Complete/Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials. SKIN The Journal of Cutaneous Medicine. 9, 1 (Jan. 2025), s520. DOI:https://doi.org/10.25251/skin.9.supp.520.